EUVIMEDEUVIMED entdecken
Crossref

Biologic therapy for psoriasis is associated with the development of metabolic dysfunction-associated steatotic liver disease (MASLD). A study on the association of cardiometabolic conditions with psoriasis treatment

Gwyneth Armijo-Borjon, Alessandra Irais Miranda-Aguirre, Arnulfo Garza-Silva, Iván Francisco Fernández-Chau, Miguel Ángel Sanz-Sánchez, Arnulfo González-Cantú, Maria Elena Romero-Ibarguengoitia

Archives of Dermatological Research · 2025

DOI: 10.1007/s00403-024-03688-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Dermatological Research, 2025. Verfasst von Gwyneth Armijo-Borjon und 6 weiteren Autor:innen. Beteiligte Einrichtung: Research Department, Hospital Clínica Nova de Monterrey, San Nicolás de los Garza, Nuevo León, México. Hauptthemen laut MEDLINE: Psoriasis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsoriasisHumansFemaleMaleMiddle AgedRetrospective StudiesAdultAgedLongitudinal StudiesDiabetes Mellitus, Type 2MexicoFatty LiverBody Mass IndexBiological TherapyBiological ProductsComorbidityPrevalence

Stichwörter der Autor:innen

ComorbidityMetabolic-associated fatty liver diseasePsoriasisSeverityTreatment

Substanzen

Biological Products

Autor:innen und Institutionen

  • Research Department, Hospital Clínica Nova de Monterrey, San Nicolás de los Garza, Nuevo León, México.
  • Dermatology Department, Hospital Clínica Nova de Monterrey, San Nicolás de los Garza, Nuevo León, México.
  • Medical School, Vice-Rectory of Health Sciences, Universidad de Monterrey, Ignacio Morones Prieto Ave. 4500 W, San Pedro Garza García, Nuevo Leon, Mexico.
  • Research Department, Hospital Clínica Nova de Monterrey, San Nicolás de los Garza, Nuevo León, México. MROMEROI@novaservicios.com.mx.

Zitieren

APA

Armijo-Borjon, G., Miranda-Aguirre, A. I., Garza-Silva, A., Fernández-Chau, I. F., Sanz-Sánchez, M. Á., González-Cantú, A., & Romero-Ibarguengoitia, M. E. (2025). Biologic therapy for psoriasis is associated with the development of metabolic dysfunction-associated steatotic liver disease (MASLD). A study on the association of cardiometabolic conditions with psoriasis treatment. Archives of Dermatological Research. https://doi.org/10.1007/s00403-024-03688-5

Vancouver

Armijo-Borjon G, Miranda-Aguirre AI, Garza-Silva A, Fernández-Chau IF, Sanz-Sánchez MÁ, González-Cantú A, et al. Biologic therapy for psoriasis is associated with the development of metabolic dysfunction-associated steatotic liver disease (MASLD). A study on the association of cardiometabolic conditions with psoriasis treatment. Archives of Dermatological Research. 2025. doi:10.1007/s00403-024-03688-5

BibTeX
@article{ArmijoBorjon2025,
  author = {Armijo-Borjon, Gwyneth and Miranda-Aguirre, Alessandra Irais and Garza-Silva, Arnulfo and Fernández-Chau, Iván Francisco and Sanz-Sánchez, Miguel Ángel and González-Cantú, Arnulfo and Romero-Ibarguengoitia, Maria Elena},
  title = {Biologic therapy for psoriasis is associated with the development of metabolic dysfunction-associated steatotic liver disease (MASLD). A study on the association of cardiometabolic conditions with psoriasis treatment},
  journal = {Archives of Dermatological Research},
  year = {2025},
  doi = {10.1007/s00403-024-03688-5}
}
Kostenlos starten →